Skip to main content

Table 1 Sociodemographic, drug use patterns, and drug use perception characteristics of 482 people who use drugs compared with willingness to use an OPC

From: Association between willingness to use an overdose prevention center and probation or parole status among people who use drugs in Rhode Island

Characteristic (n)

Overall n = 482 (%)

No, willingness to use OPC

n = 138 (29%)

Yes, willingness to use an OPC

n = 344 (71%)

p-value

Probation/parole status

0.24

 Never been on probation/parole

116 (24%)

33 (24%)

83 (24%)

 

 Not currently on probation/parole

212 (44%)

68 (49%)

144 (42%)

 

 Currently on probation or parole

154 (32%)

37 (27%)

117 (34%)

 

Sociodemographics

 

 Sex at birth

0.12

  Male

322 (67%)

85 (62%)

237 (69%)

 

  Female

160 (33%)

53 (38%)

107 (31%)

 

 Gender identitya

1.00

  Cisgender

464 (97%)

133 (97%)

331 (97%)

 

  Transgender or other

16 (3%)

4 (3%)

12 (3%)

 

 Age, median (IQR)

43 (35, 53)

45 (34, 56)

42 (35, 51)

0.07

 Racea

0.33

  White

269 (56%)

70 (52%)

199 (58%)

 

  Black

90 (19%)

32 (24%)

58 (17%)

 

  Bi/multi-racial

62 (13%)

16 (12%)

46 (13%)

 

  Other

58 (12%)

18 (13%)

40 (12%)

 

 Ethnicitya

0.82

  Non-Hispanic/Latine

383 (80%)

110 (80%)

273 (79%)

 

  Hispanic/Latine

98 (20%)

27 (20%)

71 (21%)

 

 Homelessnessa

< 0.01b

  No

231 (48%)

80 (58%)

151 (44%)

 

  Yes

250 (52%)

58 (42%)

192 (56%)

 

Drug use behaviors and patterns

 

 Regular use of crack cocainec

< 0.01b

  No

188 (39%)

71 (51%)

117 (34%)

 

  Yes

294 (61%)

67 (49%)

227 (66%)

 

 Regular use of powder cocainec

0.02b

  No

352 (73%)

111 (80%)

241 (70%)

 

  Yes

130 (27%)

27 (20%)

103 (30%)

 

 Regular use of heroinc

< 0.01b

  No

329 (68%)

114 (83%)

215 (63%)

 

  Yes

153 (32%)

24 (17%)

129 (38%)

 

Regular use of fentanyle

< 0.01b

  No

323 (67%)

110 (80%)

213 (62%)

 

  Yes

131 (27%)

17 (12%)

114 (33%)

 

  DK/R

28 (6%)

11 (8%)

17 (5%)

 

 Regular injection drug usec

< 0.01b

  No

352 (73%)

121 (88%)

231 (67%)

 

  Yes

130 (27%)

17 (12%)

113 (33%)

 

 Regular non-injection drug usec

0.21

  No

56 (12%)

20 (15%)

36 (10%)

 

  Yes

426 (88%)

118 (85%)

308 (90%)

 

 Regular concurrent drug usecd

 < 0.01b

  No

232 (48%)

93 (67%)

139 (40%)

 

  Yes

250 (52%)

45 (33%)

205 (60%)

 

 Drug dealing in the past montha

 < 0.02b

  No

358 (75%)

113 (82%)

245 (72%)

 

  Yes

120 (25%)

24 (18%)

96 (28%)

 

 Opioid agonist therapya

0.01b

  No

363 (75%)

114 (83%)

249 (72%)

 

  Yes

118 (25%)

23 (17%)

95 (28%)

 

 Have you ever seen someone overdose?a

< 0.01b

  No

68 (14%)

30 (22%)

38 (11%)

 

  Yes

412 (86%)

108 (78%)

304 (89%)

 

 Experience lifetime overdosea

< 0.01b

  No

219 (46%)

81 (60%)

138 (40%)

 

  Yes

258 (54%)

54 (40%)

204 (60%)

 

Attitudes and preferences ance use

 

 Self-concern of overdosea

0.02b

  No

195 (41%)

67 (49%)

128 (37%)

 

  Yes

286 (59%)

71 (51%)

215 (63%)

 

 Preference using fentanyl or drugs that have fentanyla

0.02b

  No

407 (85%)

125 (91%)

282 (82%)

 

  Yes

72 (15%)

12 (9%)

60 (18%)

 

 Concern about drugs containing fentanyl

0.17

  No

133 (28%)

44 (32%)

89 (26%)

 

  Yes

348 (72%)

93 (68%)

255 (74%)

 
  1. aResponses with missing data were excluded
  2. bp < 0.05
  3. cRegular use is operationalized as ≥ 4 days of use in the last month
  4. dRegular concurrent drug use is measured to be regular use of two or more of the following drugs: crack cocaine, powder cocaine, heroin, crystal methamphetamine, psychedelics, club drugs, non-prescribed prescription opioids, non-prescribed benzodiazepines, and non-prescribed methadone or buprenorphine
  5. eRegular fentanyl use is operationalized as “multiple times per day,” “every day,” or “at least every week” in the last 30 days. Non-regular fentanyl use is operationalized as “Never” or “Once or a couple of times.”